Evidence map›Paper›PMID 35615975›Full record

ArticleBioengineered2022

Senescence marker protein30 protects lens epithelial cells against oxidative damage by restoring mitochondrial function.

He Teng, Yaru Hong, Jingjing Cao, Hui Li, Fang Tian, Jing Sun, Kai Wen, Guoge Han, Amy Whelchel, Xiaomin Zhang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Cellular Senescence in Health, Disease, and Lens Aging.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

He TengTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin, China, Tianjin Branch of National Clinical Research Center for Ocular Disease, Tianjin, China, Eye Institute and School of Optometry, Tianjin, China, Tianjin Medical University Eye Hospita, Tianjin, China.
Yaru HongTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin, China, Tianjin Branch of National Clinical Research Center for Ocular Disease, Tianjin, China, Eye Institute and School of Optometry, Tianjin, China, Tianjin Medical University Eye Hospita, Tianjin, China.
Jingjing CaoTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin, China, Tianjin Branch of National Clinical Research Center for Ocular Disease, Tianjin, China, Eye Institute and School of Optometry, Tianjin, China, Tianjin Medical University Eye Hospita, Tianjin, China.
Hui LiTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin, China, Tianjin Branch of National Clinical Research Center for Ocular Disease, Tianjin, China, Eye Institute and School of Optometry, Tianjin, China, Tianjin Medical University Eye Hospita, Tianjin, China.ORCID 0000-0003-4329-3168
Fang TianTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin, China, Tianjin Branch of National Clinical Research Center for Ocular Disease, Tianjin, China, Eye Institute and School of Optometry, Tianjin, China, Tianjin Medical University Eye Hospita, Tianjin, China.
Jing SunTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin, China, Tianjin Branch of National Clinical Research Center for Ocular Disease, Tianjin, China, Eye Institute and School of Optometry, Tianjin, China, Tianjin Medical University Eye Hospita, Tianjin, China.
Kai WenTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin, China, Tianjin Branch of National Clinical Research Center for Ocular Disease, Tianjin, China, Eye Institute and School of Optometry, Tianjin, China, Tianjin Medical University Eye Hospita, Tianjin, China.
Guoge HanTianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin, China.
Amy WhelchelDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma, Ok, USA.
Xiaomin ZhangTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin, China, Tianjin Branch of National Clinical Research Center for Ocular Disease, Tianjin, China, Eye Institute and School of Optometry, Tianjin, China, Tianjin Medical University Eye Hospita, Tianjin, China.
Xiaorong LiTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin, China, Tianjin Branch of National Clinical Research Center for Ocular Disease, Tianjin, China, Eye Institute and School of Optometry, Tianjin, China, Tianjin Medical University Eye Hospita, Tianjin, China.
Lijie DongTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin, China, Tianjin Branch of National Clinical Research Center for Ocular Disease, Tianjin, China, Eye Institute and School of Optometry, Tianjin, China, Tianjin Medical University Eye Hospita, Tianjin, China.
Tianjin Medical University Eye Hospital · CNUniversity of Oklahoma Health Sciences Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Etiology and pathogenesis of age-related cataract is not entirely clear till now. Senescence marker protein 30 (SMP30) is a newly discovered anti-aging factor, which plays an important role in preventing apoptosis and reducing oxidative stress damage. Mitochondria are located at the intersection of key cellular pathways, such as energy substrate metabolism, reactive oxygen species (ROS) production and apoptosis. Oxidative stress induced by 4-hydroxynonenal (4-HNE) is closely related to neurodegenerative diseases and aging. Our study focused on the effect of SMP30 on mitochondrial homeostasis of human lens epithelial cells (HLECs) induced by 4-HNE. Western blots and qPCR were used to compare the expression of SMP30 protein in the residual lens epithelial cells in the lens capsule of age-related cataract (ARC) patients and the donated transparent lens capsule. On this basis, SMP30 overexpression plasmid and SMP30 shRNA interference plasmid were introduced to explore the effect of SMP30 on the biological behavior in HLECs under the condition of oxidative stress induced by 4-HNE through immunohistochemistry, ROS evaluation, metabolic spectrum analysis and JC-1 fluorescence measurement. Given that Nuclear Factor erythroid 2-Related Factor 2 (Nrf2)/Kelch Like ECH Associated Protein 1 (KEAP1) signaling pathway is the most important antioxidant stress pathway, we further analyzed the regulatory effect of SMP30 by WB to explore its molecular mechanism. Our study indicated that SMP30 may inhibit ROS accumulation, restore mitochondrial function, activate Nrf2/Keap1 signaling pathway, therefore protecting lens epithelial cells from oxidative stress-induced cell damage.

Indexed as

Calcium-Binding ProteinsCataractIntracellular Signaling Peptides and ProteinsMitochondriaOxidative StressApoptosisBiomarkersEpithelial CellsHumansKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Reactive Oxygen SpeciesBiomarkersCalcium-Binding ProteinsIntracellular Signaling Peptides and ProteinsKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Reactive Oxygen SpeciesRGN protein, humanhuman lens epithelial cellsmitochondrial functionNrf2/Keap1oxidative stressSenescence marker protein 30

Identifiers

PMID35615975
PMCPMC9275934
OpenAlexW4281569716

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.